{"id":"W4411424905","doi":"10.1016/j.ard.2025.06.1064","title":"ABS0080 THREE YEARS REAL WORLD PERSISTENCE DATA OF FRESENIUS KABI – ADALIMUMAB BIOSIMILAR (FK-ada), MSB11022, IN INFLAMMATORY ARTHRITIS (IA)","year":2025,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Medicine; Adalimumab; Biosimilar; Persistence (discontinuity); Arthritis; Etanercept; Immunology; Antirheumatic Agents; Inflammatory arthritis; Internal medicine; Rheumatoid arthritis","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001879775,0.0002291038,0.0003838873,0.001241112,0.0004603331,0.0008958653,0.0005239882,0.0004134684,0.001949348],"category_scores_gemma":[0.003449213,0.0001184193,0.0005945729,0.001844887,0.0002648348,0.000320642,0.0003369106,0.000499477,0.0007367324],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002009237,"about_ca_system_score_gemma":0.002045412,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.1453232,"about_ca_topic_score_gemma":0.1286076,"domain_scores_codex":[0.9989908,0.0001090295,0.0001604173,0.0001806535,0.0004353743,0.0001236334],"domain_scores_gemma":[0.9937883,0.0008002637,0.002210098,0.0005424241,0.002037789,0.0006209932],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.003224547,0.000153277,0.9854417,0.00009488175,0.0002545466,0.00008127756,0.0001095371,0.00046667,0.0004578891,0.00005780132,0.001796579,0.007861316],"study_design_scores_gemma":[0.0001200858,0.0005045838,0.995428,0.00002478718,0.0001347564,0.0001868062,0.0001004644,0.0006954487,0.0003100345,0.00002649703,0.002456458,0.00001208542],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691147,0.0004838382,0.000162367,0.00008274268,0.000009687933,0.00003341395,0.02881173,0.00002437328,0.001277215],"genre_scores_gemma":[0.9615914,0.0001949287,0.0002151925,0.00005952866,0.00001635217,0.00003886002,0.037045,0.000007028723,0.0008316551],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1453232,"threshold_uncertainty_score":0.2889546,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06645904673448745,"score_gpt":0.3440475213404774,"score_spread":0.27758847460599,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}